These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15775264)

  • 1. [Intervention therapy for secondary hyperparathyroidism].
    Kakuta T
    Clin Calcium; 2002 Dec; 12(12):1679-86. PubMed ID: 15775264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
    Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
    Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
    Uemura K; Kakuta T
    Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
    Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.
    Nakanishi S; Yano S; Nomura R; Tsukamoto T; Shimizu Y; Shin J; Fukagawa M
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii47-9. PubMed ID: 12771300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis of parathyroid function after successful percutaneous ethanol injection therapy (PEIT) guided by color Doppler flow mapping in chronic dialysis patients.
    Kakuta T; Kunimatsu K; Tadaki F; Fujisaki T; Noguchi M; Abe Y; Sakai H; Kurokawa K; Saito A
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():60s-65s. PubMed ID: 10914993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism.
    de Barros Gueiros JE; Chammas MC; Gerhard R; da Silva Dias Boilesen CF; de Oliveira IR; Moysés RM; Jorgetti V
    Nephrol Dial Transplant; 2004 Mar; 19(3):657-63. PubMed ID: 14767023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.
    Yamamoto H; Katoh N; Takeyama H; Ikeda M; Yokoyama K; Shigematsu T; Kawaguchi Y; Hosoya T
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii50-2. PubMed ID: 12771301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention.
    Kakuta T; Fukagawa M; Kitaoka M; Koiwa F; Onoda N; Tominaga Y; Akizawa T; Kurokawa K;
    NDT Plus; 2008 Aug; 1(Suppl 3):iii21-iii25. PubMed ID: 25983968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism.
    Douthat WG; Orozco SE; Maino P; Cardozo G; de Arteaga J; de la Fuente J; Chiurchiu CR; Massari PU
    Transpl Int; 2007 Dec; 20(12):1031-5. PubMed ID: 17883371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients.
    Onoda N; Kashiwagi T; Nakamura T; Niitsu Y; Omata M; Kurihara S
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S11-5. PubMed ID: 16109135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous ethanol injection treatment of severe hyperparathyroidism in maintenance dialysis: risks and benefits.
    Guebre-Egziabher F; Easy F; Juillard L; Valette PJ; Fouque D
    Hemodial Int; 2004 Jul; 8(3):214-8. PubMed ID: 19379420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients--the Japanese strategy. Japanese Working Group on PEIT of Parathyroid, Tokyo, Japan.
    Fukagawa M; Kitaoka M; Tominaga Y; Akizawa T; Kurokawa K
    Nephrol Dial Transplant; 1999 Nov; 14(11):2574-7. PubMed ID: 10534489
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the parathyroid gland vascularization index in predicting percutaneous ethanol injection efficacy in refractory uremic hyperparathyroidism.
    Chen HH; Lu KC; Lin CJ; Wu CJ
    Nephron Clin Pract; 2011; 117(2):c120-6. PubMed ID: 20693813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients.
    Onoda N; Fukagawa M; Tominaga Y; Kitaoka M; Akizawa T; Koiwa F; Kakuta T; Kurokawa K;
    NDT Plus; 2008 Aug; 1(Suppl 3):iii26-iii28. PubMed ID: 25983969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.
    Fukagawa M; Kitaoka M; Tominaga Y; Akizawa T; Kakuta T; Onoda N; Koiwa F; Yumita S; Kurokawa K;
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii31-3. PubMed ID: 12771296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy.
    Chen HH; Hsu MT; Wu CJ; Chen YW; Yang TL
    Am J Surg; 2008 Aug; 196(2):155-9. PubMed ID: 18513687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of regular dialysis treatment in Japan (as of 31 December 2004).
    Nakai S; Wada A; Kitaoka T; Shinzato T; Nagura Y; Kikuchi K; Masakane I; Shinoda T; Yamazaki C; Sakai R; Marubayashi S; Morita O; Iseki K; Usami T; Kimata N; Suzuki K; Tabei K; Fushimi K; Miwa N; Yauchi M; Wakai K; Akiba T
    Ther Apher Dial; 2006 Dec; 10(6):476-97. PubMed ID: 17199880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management after parathyroid intervention.
    Tanaka M; Fukagawa M
    NDT Plus; 2008 Aug; 1(Suppl 3):iii18-iii20. PubMed ID: 25983966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.